Post by Ypsomed AG

40,508 followers

Q1 FY2026/27 Update from Ypsomed šŸ“¢. CEO Simon Michel provides an update on Ypsomed's first quarter of fiscal year 2026/27. Thanks to new customer projects spanning many therapeutic areas, international recognition for its innovation, and the planned expansion of manufacturing capacity, the company enjoyed a strong start to the new fiscal year šŸ“ˆ. Read more šŸ‘‰ https://lnkd.in/ed_icJbq Ā  #ypsomed #MedTech #innovation #FY2627 #InvestorUpdate

Post content

Video Content